Publications

Junk, Damian J, et al. “Different Mutant Wild-Type P53 Combinations Cause a Spectrum of Increased Invasive Potential in Nonmalignant Immortalized Human Mammary Epithelial Cells.”. Neoplasia, vol. 10, no. 5, May 2008, pp. 450-61.

Brinton, Roberta Diaz, et al. “Progesterone Receptors: Form and Function in Brain.”. Front Neuroendocrinol, vol. 29, no. 2, May 2008, pp. 313-39, https://doi.org/10.1016/j.yfrne.2008.02.001.

Wang, Jun Ming, et al. “Regenerative Potential of Allopregnanolone.”. Brain Res Rev, vol. 57, no. 2, Mar. 2008, pp. 398-09, https://doi.org/10.1016/j.brainresrev.2007.08.010.

Watts, George S, et al. “DNA Methylation Changes in Ovarian Cancer Are Cumulative With Disease Progression and Identify Tumor Stage.”. BMC Med Genomics, vol. 1, Jan. 2008, p. 47, https://doi.org/10.1186/1755-8794-1-47.

Wang, Jun Ming, et al. “Estradiol-17beta-Induced Human Neural Progenitor Cell Proliferation Is Mediated by an Estrogen Receptor Beta-Phosphorylated Extracellularly Regulated Kinase Pathway.”. Endocrinology, vol. 149, no. 1, Jan. 2008, pp. 208-18, https://doi.org/10.1210/en.2007-1155.

Brinton, Roberta Diaz. “Estrogen Regulation of Glucose Metabolism and Mitochondrial Function: Therapeutic Implications for Prevention of Alzheimer’s Disease.”. Adv Drug Deliv Rev, vol. 60, no. 13-14, Jan. 2008, pp. 1504-11, https://doi.org/10.1016/j.addr.2008.06.003.

Tumati, Suneeta, et al. “Intrathecal Raf-1-Selective SiRNA Attenuates Sustained Morphine-Mediated Thermal Hyperalgesia.”. Eur J Pharmacol, vol. 601, no. 1-3, Jan. 2008, pp. 207-8, https://doi.org/10.1016/j.ejphar.2008.10.033.

Vanderah, Todd W, et al. “Novel D-Amino Acid Tetrapeptides Produce Potent Antinociception by Selectively Acting at Peripheral Kappa-Opioid Receptors.”. Eur J Pharmacol, vol. 583, no. 1, Jan. 2008, pp. 62-72, https://doi.org/10.1016/j.ejphar.2008.01.011.

Streicher, J M, and Wang, Y. “The Role of COX-2 in Heart Pathology.”. Cardiovasc Hematol Agents Med Chem, vol. 6, no. 1, Jan. 2008, pp. 69-79.

Goulet, Anne-Christine, et al. “Profiling of Selenomethionine Responsive Genes in Colon Cancer by Microarray Analysis.”. Cancer Biol Ther, vol. 6, no. 4, Apr. 2007, pp. 494-03.

Watts, George S, et al. “Identification of Fn14 TWEAK Receptor As a Potential Therapeutic Target in Esophageal Adenocarcinoma.”. Int J Cancer, vol. 121, no. 10, Jan. 2007, pp. 2132-9, https://doi.org/10.1002/ijc.22898.

Ignatenko, Natalia A, et al. “Pharmacogenomics of the Polyamine Analog 3,8,13,18-Tetraaza-10,11-[(E)-1,2-Cyclopropyl]eicosane Tetrahydrochloride, CGC-11093, in the Colon Adenocarcinoma Cell Line HCT1161.”. Technol Cancer Res Treat, vol. 5, no. 6, Dec. 2006, pp. 553-64, https://doi.org/10.1177/153303460600500602.

Li, H, et al. “AP-2alpha and AP-2gamma Are Transcriptional Targets of P53 in Human Breast Carcinoma Cells.”. Oncogene, vol. 25, no. 39, Jan. 2006, pp. 5405-15, https://doi.org/10.1038/sj.onc.1209534.

Novak, Petr, et al. “Epigenetic Inactivation of the HOXA Gene Cluster in Breast Cancer.”. Cancer Res, vol. 66, no. 22, Jan. 2006, pp. 10664-70, https://doi.org/10.1158/0008-5472.CAN-06-2761.

Sparks, D Larry, et al. “Atorvastatin Therapy Lowers Circulating Cholesterol But Not Free Radical Activity in Advance of Identifiable Clinical Benefit in the Treatment of Mild-to-Moderate AD.”. Curr Alzheimer Res, vol. 2, no. 3, July 2005, pp. 343-53.

Sparks, D Larry, et al. “Atorvastatin for the Treatment of Mild to Moderate Alzheimer Disease: Preliminary Results.”. Arch Neurol, vol. 62, no. 5, May 2005, pp. 753-7, https://doi.org/10.1001/archneur.62.5.753.

Bethea, C L, et al. “Serotonin-Related Gene Expression in Female Monkeys With Individual Sensitivity to Stress.”. Neuroscience, vol. 132, no. 1, Jan. 2005, pp. 151-66, https://doi.org/10.1016/j.neuroscience.2004.11.022.

Sparks, D.L., et al. “Water Quality and Cholesterol-Induced Pathology: Differential Effects of the M-1 Muscarinic Receptor Agaonist AF267b on Accumulation of Alzheimer-Like Amyloid B in Rabbit Brain”. Recent Progress in Alzheimer’s and Parkinson’s Diseases, Taylor & Francis, 2005, pp. 197-03.

Ignatenko, Natalia A, et al. “The Chemopreventive Agent Alpha-Difluoromethylornithine Blocks Ki-Ras-Dependent Tumor Formation and Specific Gene Expression in Caco-2 Cells.”. Mol Carcinog, vol. 39, no. 4, Apr. 2004, pp. 221-33, https://doi.org/10.1002/mc.20008.

Shippy, Richard, et al. “Performance Evaluation of Commercial Short-Oligonucleotide Microarrays and the Impact of Noise in Making Cross-Platform Correlations.”. BMC Genomics, vol. 5, Jan. 2004, p. 61, https://doi.org/10.1186/1471-2164-5-61.

Huan, Jian-Ya, et al. “Proteasome-Dependent Degradation of Cytochromes P450 2E1 and 2B1 Expressed in Tetracycline-Regulated HeLa Cells.”. Toxicol Appl Pharmacol, vol. 199, no. 3, Jan. 2004, pp. 332-43, https://doi.org/10.1016/j.taap.2003.12.019.

Watts, George S, et al. “The Acetyltransferase P300 CBP-Associated Factor Is a P53 Target Gene in Breast Tumor Cells.”. Neoplasia, vol. 6, no. 3, Jan. 2004, pp. 187-94, https://doi.org/10.1593/neo.3292.

Zheng, Xing Hui, et al. “Low-Level Arsenite Induced Gene Expression in HEK293 Cells.”. Toxicology, vol. 187, no. 1, Jan. 2003, pp. 39-48.

Oshiro, Marc M, et al. “Mutant P53 and Aberrant Cytosine Methylation Cooperate to Silence Gene Expression.”. Oncogene, vol. 22, no. 23, Jan. 2003, pp. 3624-34, https://doi.org/10.1038/sj.onc.1206545.

Crowley-Weber, Cara L, et al. “Development and Molecular Characterization of HCT-116 Cell Lines Resistant to the Tumor Promoter and Multiple Stress-Inducer, Deoxycholate.”. Carcinogenesis, vol. 23, no. 12, Dec. 2002, pp. 2063-80.